Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease

Ellen De Beer, Emily Delgouffe, Pauline Mazilier, Ellen Goossens

Open source

DOI
10.3389/fendo.2026.1979188
Published
2026-10-08
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1979188,
  title = {Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease},
  author = {Ellen De Beer and Emily Delgouffe and Pauline Mazilier and Ellen Goossens},
  year = {2026},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2026.1979188},
  url = {https://doi.org/10.3389/fendo.2026.1979188}
}

RIS

TY  - JOUR
TI  - Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease
AU  - Ellen De Beer
AU  - Emily Delgouffe
AU  - Pauline Mazilier
AU  - Ellen Goossens
PY  - 2026
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1979188
UR  - https://doi.org/10.3389/fendo.2026.1979188
ER  - 

APA

Beer, E. D., Delgouffe, E., Mazilier, P., & Goossens, E. (2026). Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1979188

Source records